LEARN

annabis and its many derivative compounds are a new wave in pharmaceuticals and dermatological formulations. Many brands that have not explored these until now are eager to get their feet wet in this promising new field. This change has come about thanks to more information, more research that is now available about these products.

Epilepsy is a chronic neurological disorder that is non-communicable in nature. Recurrent seizures are the main characteristics of epilepsy. These seizures can be partial where there is an involuntary movement of a part of the individual’s body or generalized where the entire body experiences these involuntary movements.

The use of CBD in treating eczema has been extensively researched in recent times and the results have been favorable. The National Eczema.org website has information about CBD’s effects on atopic dermatitis, often clubbed with eczema. CBD has received a glowing report by none other than the founding editor of the JAMA Dermatology and one of the founding fathers of American Dermatology, Dr. Henry Piffard.

While there are numerous researches going on in this respect, one of the most crucial ones is related to rheumatoid arthritis. Researchers are not only looking at understanding the pathogenesis of rheumatoid arthritis but also identifying CBD products can help relieve its symptoms.